The secondary outcomes were mean change in best-corrected visual acuity ( BCVA ) [ Early Treatment Diabetic Retinopathy study ( ETDRS ) ] , clinical CME incidence , intraocular pressure , and retinal thickness measured using optical coherence tomography ( OCT ) .